<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26609" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Paracoccidioidomycosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cordova</surname>
            <given-names>Leopoldo A.</given-names>
          </name>
          <aff>Aventura Hospital &#x00026; Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Torres</surname>
            <given-names>Jaime</given-names>
          </name>
          <aff>UCV</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Leopoldo Cordova declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jaime Torres declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26609.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Paracoccidioidomycosis (PCM) is a systemic fungal infection caused by a dimorphic fungus endemic in Central and South America. The morbidity and mortality caused by this infection are strongly associated with early recognition, choice of therapy, and medication compliance. This activity describes the etiology, pathophysiology, and evaluation of paracoccidioidomycosis and highlights the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Determine&#x000a0;the pathophysiology of paracoccidioidomycosis.</p></list-item><list-item><p>Assess&#x000a0;the appropriate evaluation of paracoccidioidomycosis.</p></list-item><list-item><p>Compare&#x000a0;the management options for paracoccidioidomycosis.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving care coordination amongst the interprofessional team to improve outcomes for patients affected by paracoccidioidomycosis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26609&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26609">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26609.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Paracoccidioidomycosis (PCM) is a systemic fungal infection caused by a dimorphic fungus endemic to the Americas, found from Mexico to Argentina, with the highest incidence in Brazil, Venezuela, and Colombia.<xref ref-type="bibr" rid="article-26609.r1">[1]</xref>&#x000a0;PCM is the most frequent systemic, endemic mycosis in this region and was first recognized by Adolfo Lutz in Brazil in 1908. Later, Splendore described the fungus's morphology and&#x000a0;4 clinical cases. In 1930, Floriano Paulo de Almeida named the causing agent <italic toggle="yes">Paracoccidiodes brasiliensis</italic>. This disease is caused by a&#x000a0;thermally dimorphic fungus from the genus&#x000a0;Paracoccidioides. PCM can also be caused by other species of this genus, including&#x000a0;<italic toggle="yes">P americana, P restrepiensis, P venezuelensis,</italic> and <italic toggle="yes">P lutzii</italic>.<xref ref-type="bibr" rid="article-26609.r2">[2]</xref>&#x000a0;<italic toggle="yes">Paracoccidioides brasiliensis</italic>&#x000a0;and <italic toggle="yes">Paracoccidioides lutzii</italic>&#x000a0;are considered the primary pathogens, given the high isolation rate of these strains.<xref ref-type="bibr" rid="article-26609.r1">[1]</xref></p>
      </sec>
      <sec id="article-26609.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The genus <italic toggle="yes">Paracoccidioides</italic> belongs to the phylum Ascomycota, order Onygenales. It includes species from different phylogenetic lineages: PS1 (more frequent in South America), PS2 (found in Brazil and Venezuela), PS3 (found in Colombia), and PS4 (limited to Venezuela).<xref ref-type="bibr" rid="article-26609.r3">[3]</xref><xref ref-type="bibr" rid="article-26609.r4">[4]</xref>&#x000a0;In "Diagnosis and Treatment of Human Mycoses," Hospenthal describes&#x000a0;<italic toggle="yes">Paracoccidioides</italic>&#x000a0;as a dimorphic fungus with mycelial growth at 22&#x000b0; to 24&#x000b0; C, displaying thin septated hyphae, occasional chlamydospores, and conidia. It also describes their growth as yeast, growing at 36&#x000b0; to 37&#x000b0; C, identified by multiple-budding yeast cells (&#x0201c;pilot&#x02019;s wheel&#x0201d;). The&#x000a0;2 main species lack a sexual stage (teleomorph).&#x000a0;<italic toggle="yes">Paracoccidioides</italic> grow in the soil in humid regions with a medium to high rainy season, mild temperatures, and forests and rivers.<xref ref-type="bibr" rid="article-26609.r3">[3]</xref>&#x000a0;Characteristically, <italic toggle="yes">Paracoccidioides</italic> infection is reported in areas of coffee and tobacco crops. The main accidental hosts are humans and 9-banded armadillos (Dasypus novemcinctus). Inter-human transmission has not yet been reported.<xref ref-type="bibr" rid="article-26609.r4">[4]</xref></p>
      </sec>
      <sec id="article-26609.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p><italic toggle="yes">Paracoccidioides</italic> has a geographic distribution primarily limited to certain regions of Central and South America. About 80% of cases have been reported in Brazil, followed by Colombia, Venezuela, and Ecuador.<xref ref-type="bibr" rid="article-26609.r5">[5]</xref><xref ref-type="bibr" rid="article-26609.r6">[6]</xref>&#x000a0;The infection has been reported as far north as Mexico and south as Argentina.<xref ref-type="bibr" rid="article-26609.r7">[7]</xref><xref ref-type="bibr" rid="article-26609.r8">[8]</xref>&#x000a0;However, PCM has not been observed in certain countries of the continent, such as Chile, Surinam, Guyana, Nicaragua, Belize, and most of the Caribbean islands.<xref ref-type="bibr" rid="article-26609.r9">[9]</xref>&#x000a0;The prevalence of positive intradermal tests with <italic toggle="yes">Paracoccidioides</italic> in endemic areas could be as high as 50 to 75 percent among the adult population. Nearly 10 million patients are infected in Latin America by this pathogen, although only 1 to 2% eventually develop any clinical form of the disease.<xref ref-type="bibr" rid="article-26609.r10">[10]</xref>&#x000a0;Incidence rates range from 1 to 4 cases&#x000a0;per 100,000 inhabitants per year in geographic areas with stable endemicity of 9 to 40 cases /100.000 inhabitants per year in hyperendemic areas, such as the west Amazon region and southeastern part of Rond&#x000f4;nia state, in Brazil. Less than 5% of patients with PCM are expected to die from the disease.<xref ref-type="bibr" rid="article-26609.r4">[4]</xref></p>
        <p>PCM has particular predisposing and modulating factors that differ from other endemic mycoses. After puberty, the illness affects predominantly males (75% to 95% of cases), even though women are equally exposed to the fungus. The presence of circulating estrogens has been described as inhibiting the transformation from conidia to yeasts and modulating the cellular immune response.<xref ref-type="bibr" rid="article-26609.r11">[11]</xref>&#x000a0;Indeed,&#x000a0;when women develop symptomatic infections, the disease paradoxically is often&#x000a0;more severe and disseminated. Moreover, cases of reactivation of the infection have been described during pregnancy.<xref ref-type="bibr" rid="article-26609.r4">[4]</xref>&#x000a0;</p>
        <p>PCM is an occupational disease mostly related to farmers who&#x000a0;live in rural areas. Workers involved in coffee and tobacco crops have an increased risk of acquiring the infection. PCM has also been reported among professionals exposed to aerosols containing soil particles.<xref ref-type="bibr" rid="article-26609.r4">[4]</xref>&#x000a0;The chronic form of the infection has a strong association with smoking. The risk of developing diseases is 14 times higher in smokers than in nonsmokers. Alcohol intake in quantities exceeding 50 g per day also favors the onset of PCM.<xref ref-type="bibr" rid="article-26609.r4">[4]</xref></p>
        <p>The disease has been rarely associated with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) but has been reported in association with tuberculosis in 15 to 20% of patients. Regarding cancer and solid organ transplantation, a few cases of concurrent infection have been reported.<xref ref-type="bibr" rid="article-26609.r12">[12]</xref></p>
      </sec>
      <sec id="article-26609.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p><italic toggle="yes">Paracoccidioides</italic> infection is acquired mainly via inhalation of conidia and, more rarely, by direct inoculation of the skin or oral mucosa (due to using twigs to clean teeth). A non-specific inflammatory response is initiated once the fungus invades the lungs in the yeast form. Neutrophils and alveolar macrophages tend to form granulomas depending on the immunological state of the patient and the T helper (TH) lymphocytes' response. TH1 responses have been associated with a localized process that generally limits the infection. On the other hand, TH2 responses are associated with the disseminated form and a worse clinical outcome.<xref ref-type="bibr" rid="article-26609.r13">[13]</xref><xref ref-type="bibr" rid="article-26609.r14">[14]</xref></p>
        <p>After the primary infection, the host forms granulomas. In children, adolescents, and immunocompromised patients, the infection could progress rapidly to systemic disease (acute/subacute infection). On the other hand, in adults, the agent may disseminate through the lymphatic vessels and veins, usually after several years (chronic infection), and depending on the host&#x02019;s immunological response, can cause granulomas in multiple organs and tissues.<xref ref-type="bibr" rid="article-26609.r10">[10]</xref></p>
        <p>The chronic form usually results from the reactivation of latent pulmonary foci formed during the primary infection, but reinfections may also occur.&#x000a0;PCM has an insidious course in which the lung is the most frequently affected organ, with lesser involvement of the reticuloendothelial and lymphatic systems. Pulmonary manifestations are observed in about 90% of the patients with chronic disease; however, respiratory complaints are seldom the main reason for medical consultation.<xref ref-type="bibr" rid="article-26609.r15">[15]</xref><xref ref-type="bibr" rid="article-26609.r16">[16]</xref>&#x000a0;Lung sequelae in pulmonary PCM are reported in more than 50% of patients in advanced stages of the disease, even after effective treatment, and may severely impair respiratory function.<xref ref-type="bibr" rid="article-26609.r16">[16]</xref></p>
        <p>Unifocal pulmonary involvement occurs in only 25% of the cases. Most patients seek medical consultation only after dissemination to extra-pulmonary sites or multifocal diseases.<xref ref-type="bibr" rid="article-26609.r16">[16]</xref>&#x000a0;After dissemination, secondary lesions can affect numerous tissues, including mucous membranes and skin. The frequent involvement of the oral mucosa prompts patients to seek dental or medical consultation when the diagnosis is made.<xref ref-type="bibr" rid="article-26609.r16">[16]</xref>&#x000a0;Other sites of involvement include the adrenal glands, long bones,&#x000a0;and the central nervous system (CNS). CNS involvement may result in meningoencephalitis (as part of a disseminated syndrome).</p>
      </sec>
      <sec id="article-26609.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Most patients (greater than 95%)&#x000a0;are asymptomatic and develop an asymptomatic pulmonary infection that can only be detected by the intradermal paracoccidioidin test.<xref ref-type="bibr" rid="article-26609.r17">[17]</xref> In those patients who do manifest the disease,&#x000a0;2 clinical forms have been described: the juvenile (acute/subacute) form and the chronic adult form.</p>
        <p>
<bold>Juveline Form (Acute/Subacute Paracoccydiomycosis)</bold>
</p>
        <p>The juvenile form is seen in approximately 10% of the cases.<xref ref-type="bibr" rid="article-26609.r5">[5]</xref>&#x000a0;It usually appears within 45 days after exposure&#x000a0;and is generally seen in children, adolescents, and adults less than 30 years old.<xref ref-type="bibr" rid="article-26609.r18">[18]</xref>&#x000a0;The clinical manifestations are constitutional symptoms, such as fever, weight loss, malaise associated with multiple skin lesions, lymphadenopathies, draining fistulae, hepatic and splenic enlargement due to reticuloendothelial involvement, and/or bone marrow dysfunctions. Of note, in this form, mucosal and respiratory manifestations are unusual. This&#x000a0;is a progressive and more severe form of the disease. Physical exam findings include enlarged lymph nodes, abscesses, or draining fistulae.<xref ref-type="bibr" rid="article-26609.r17">[17]</xref></p>
        <p>
<bold>Chronic Form (Reactivation Paracoccydiomycosis)</bold>
</p>
        <p>The adult or chronic form is seen in 80 to 90% of the cases and is more frequent in adult men. Clinical manifestations are primarily related to lung infection, including fever, malaise, cough, and dyspnea. One-third of the patients present with pulmonary sequelae such as pulmonary fibrosis, bullae, and pulmonary hypertension. As mentioned, this is a reactivation and can occur&#x000a0;months to years after the primary infection. Pulmonary involvement is the most frequent manifestation. Enlarged lymph nodes are not common, except in children.&#x000a0;In over 50% of the cases, there is a hematogenous spread with mucous membrane involvement. It&#x000a0;usually includes&#x000a0;laryngeal and pharyngeal lesions resulting in dysphonia, dysphagia, stridor, and perioral granulomatous plaques. Gingival involvement is frequent and may lead to tooth loss. Characteristic oral mulberry-like erosions (Aguiar-Pupo stomatitis) may be associated with nasal and pharyngeal ulcers.<xref ref-type="bibr" rid="article-26609.r19">[19]</xref> Cervical chronic lymphadenopathies may be seen, along with axillary and inguinal adenopathy. In the case of intra-abdominal lymph node involvement, patients may present with diffuse abdominal pain and jaundice due to biliary tract compression. Partial intestinal obstruction can also be observed. Malabsorption syndrome may occur in cases with mesenteric lymph node fibrosis.</p>
        <p>Cutaneous lesions are seen in 25% of the cases. Ulcers, crusted papules, nodules, plaques, and verrucous lesions are typical. Generally, they are caused by hematologic dissemination from the lungs. In rare cases, these lesions result from direct inoculation.<xref ref-type="bibr" rid="article-26609.r20">[20]</xref></p>
      </sec>
      <sec id="article-26609.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis includes visualization of fungal elements suggestive of <italic toggle="yes">Paracoccidioides </italic>species&#x000a0;by direct microscopy and/or culture specimens, biopsy and histopathology, and serologic testing. Microscopic visualization: Direct examination with potassium hydroxide (KOH) is positive in about 90% of the cases with a suppurative skin lesion and in sputum samples or biopsy material from affected sites. It reveals spherical thick-walled yeast cells of variable size, with peripheral buds&#x000a0;protruding from&#x000a0;a&#x000a0;central cell (pilot's wheel).<xref ref-type="bibr" rid="article-26609.r21">[21]</xref><xref ref-type="bibr" rid="article-26609.r22">[22]</xref>&#x000a0;It is often described as multipolar budding yeast with daughter cells resembling a &#x0201c;Mickey mouse head&#x0201d; or a &#x0201c;steering wheel.&#x0201d;<xref ref-type="bibr" rid="article-26609.r17">[17]</xref>&#x000a0;This remains the cornerstone diagnostic tool due to its specificity and rapid yield.<xref ref-type="bibr" rid="article-26609.r17">[17]</xref>&#x000a0;</p>
        <p>Culture: Sabouraud dextrose agar is the ideal fungal media to recover&#x000a0;<italic toggle="yes">Paracoccidiodes. </italic>However, the fungi grow in 20 to 30 days due to the slow yield, and their utility in diagnosis remains low<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-26609.r17">[17]</xref>&#x000a0;</p>
        <p>Histologic findings: Methenamine silver stain or periodic acid Schiff stain are used to identify fungal elements in tissue samples. Histopathologic findings reveal epithelioid and giant cells and cellular infiltrates of polymorphonuclear leukocytes, monocytes, and macrophages surrounding the multiple budding yeasts.<xref ref-type="bibr" rid="article-26609.r5">[5]</xref>&#x000a0;In skin and mucous membrane lesions, pseudo-epitheliomatous hyperplasia with intra-epidermal abscesses may be seen. Lymph nodes may exhibit caseous necrosis. In the juvenile form, a&#x000a0;diffuse tissue reaction is characteristic.&#x000a0;</p>
        <p>Blood tests are useful for diagnosis and monitoring response to therapy.<xref ref-type="bibr" rid="article-26609.r23">[23]</xref>&#x000a0;Quantitative immunodiffusion testing is the most widely available assay in endemic regions and represents a reliable method with 84.3% sensitivity and 98.9% specificity. In patients with <italic toggle="yes">P lutzii</italic>, this technique may give negative results as there are no validated serological techniques for diagnosing infection with <italic toggle="yes">P lutzii</italic>.<xref ref-type="bibr" rid="article-26609.r17">[17]</xref>&#x000a0; Counterimmunoelectrophoresis shows a sensitivity between 77%&#x000a0;to 100% and a specificity greater than 95%.<xref ref-type="bibr" rid="article-26609.r24">[24]</xref><xref ref-type="bibr" rid="article-26609.r20">[20]</xref>&#x000a0;Other techniques, such as complement fixation and ELISA, have limited utility due to antigenic cross-reactivity, especially with <italic toggle="yes">Histoplasma capsulatum</italic> and <italic toggle="yes">Aspergillus.</italic><xref ref-type="bibr" rid="article-26609.r25">[25]</xref></p>
        <p>Skin testing can be positive in a healthy individual from endemic areas. This is not a useful test for diagnosing active disease, and the sensitivity is limited in severely ill patients.<xref ref-type="bibr" rid="article-26609.r17">[17]</xref>&#x000a0;</p>
        <p>General laboratory abnormalities noted in children with acute PCM include anemia (90%), hypergammaglobulinemia (89%), eosinophilia (76%), hypoalbuminemia (73%), hyperbilirubinemia (44%), and mildly elevated transaminases (20%).<xref ref-type="bibr" rid="article-26609.r26">[26]</xref></p>
      </sec>
      <sec id="article-26609.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>In 2017, the Brazilian guidelines for the clinical management of paracoccidioidomycosis were&#x000a0;published, including a detailed discussion of outpatient treatments, severe disease forms, and disease prevalence among special populations, outlined below.<xref ref-type="bibr" rid="article-26609.r23">[23]</xref>&#x000a0;Paracoccidioidomycosis infections have a high incidence in Central and South America. However, robust evidence regarding treatment efficacy is still lacking.&#x000a0;PCM has been treated with antifungal agents including ketoconazole, itraconazole, voriconazole, posaconazole, terbinafine, and amphotericin B.<xref ref-type="bibr" rid="article-26609.r27">[27]</xref>&#x000a0;Fluconazole is not commonly used because of its lower response rate and more frequent relapses. Trimethoprim-sulfamethoxazole has been studied for the treatment of PCM. However, it has been shown to require a longer duration of therapy (at least 24 months), with lower cure rates and higher relapse rates when compared to itraconazole.<xref ref-type="bibr" rid="article-26609.r28">[28]</xref><xref ref-type="bibr" rid="article-26609.r24">[24]</xref>&#x000a0;It is, therefore, not the primary choice of therapy for PCM. In general, the treatment should be continued until there is the resolution of symptoms and radiologic signs of infection along with a substantial decrease in serum serologic titers. In severe diseases, the duration of treatment should be longer than the drug-specific recommended duration.</p>
        <p>
<bold>Itraconazole</bold>
</p>
        <p>Itraconazole is the treatment of choice in mild to moderate cases due to its high response rate.<xref ref-type="bibr" rid="article-26609.r27">[27]</xref>&#x000a0;The recommended dose range is between 100 mg to 400 mg once daily. The pediatric dose of itraconazole is 5 to 10 mg/kg once daily (maximum dose 200 mg). The duration of therapy is 6 months. Efficacy has been reported as high as 91%.<xref ref-type="bibr" rid="article-26609.r29">[29]</xref>&#x000a0;It is important to remember that capsule formulations of the drug require gastric acidity to enhance absorption. Patients taking acid-suppressive therapy should not take itraconazole capsule formulation. The relapse rate with itraconazole is less than 5% if the treatment course is completed.<xref ref-type="bibr" rid="article-26609.r30">[30]</xref></p>
        <p>
<bold>Voriconazole</bold>
</p>
        <p>Voriconazole 400 mg twice daily on the first day and 200 mg twice daily after that was as effective as itraconazole for chronic PCM in a small open-label comparative study of 53 patients.<xref ref-type="bibr" rid="article-26609.r31">[31]</xref>&#x000a0;Duration of therapy is recommended between 6 to 12 months.</p>
        <p>
<bold>Ketoconazole</bold>
</p>
        <p>In small observational studies, Ketoconazole has a cure rate of 85% to 90% and a relapse rate of less than 10%. The dose was 5 mg/kg/day in children or 200&#x000a0;to 400 mg/day in adults for 6&#x000a0;to 18 months.<xref ref-type="bibr" rid="article-26609.r27">[27]</xref></p>
        <p>
<bold>Amphotericin B</bold>
</p>
        <p>Amphotericin B deoxycholate is reserved for severe PCM. It is the treatment of choice in patients with PCM sepsis. Lipid formulation of amphotericin B has demonstrated efficacy with lower adverse side effects when used to treat severe cases of PCM. Observational studies with a small number of cases show high efficacy (greater than 95%) in patients with severe PCM.<xref ref-type="bibr" rid="article-26609.r32">[32]</xref><xref ref-type="bibr" rid="article-26609.r33">[33]</xref>&#x000a0;Amphotericin B was shown to have a relapse rate of 20 to 30%.<xref ref-type="bibr" rid="article-26609.r5">[5]</xref>&#x000a0;A step-down approach with a transition to itraconazole in patients initially treated with amphotericin B has been shown to decrease relapse rates.<xref ref-type="bibr" rid="article-26609.r5">[5]</xref>&#x000a0;</p>
        <p>
<bold>Trimethoprim-sulfamethoxazole</bold>
</p>
        <p>A second-line medication is trimethoprim-sulfamethoxazole (TMP/SMX) 160/800mg twice daily, which has a lower cure rate than itraconazole (51% versus 86%, respectively). The median treatment time is 23 months with TMP/SMX, compared to 12 months for itraconazole.<xref ref-type="bibr" rid="article-26609.r24">[24]</xref></p>
        <p>
<bold>Sulfadiazine</bold>
</p>
        <p>Sulfadiazine is another alternative, the maximum dose is 4 g/day in adults and should be given until clinical and mycologic response is noted. Then, the dose can be reduced by half and maintained for 3 to 5 years. Cure rates of 70% are expected, but relapse rates may be as high as 30%.<xref ref-type="bibr" rid="article-26609.r27">[27]</xref></p>
      </sec>
      <sec id="article-26609.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis includes other granulomatous diseases and endemic infections:</p>
        <list list-type="bullet">
          <list-item>
            <p>Blastomycosis</p>
          </list-item>
          <list-item>
            <p>Actinomycosis</p>
          </list-item>
          <list-item>
            <p>Histoplasmosis</p>
          </list-item>
          <list-item>
            <p>Coccidioidomycosis</p>
          </list-item>
          <list-item>
            <p>Leishmaniasis</p>
          </list-item>
          <list-item>
            <p>Leprosy</p>
          </list-item>
          <list-item>
            <p>Lobomycosis</p>
          </list-item>
          <list-item>
            <p>Lymphomas</p>
          </list-item>
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
          <list-item>
            <p>Sporotrichosis</p>
          </list-item>
          <list-item>
            <p>Wegener granulomatosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26609.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>PCM is a disease with high morbidity but relatively low&#x000a0;lethality, except in immunosuppressed patients or cases with CNS involvement, in which the prognosis is poor. Recent studies indicate a&#x000a0;case fatality rate of 7.6% for adults and 9.3% among children.<xref ref-type="bibr" rid="article-26609.r30">[30]</xref>&#x000a0;Relapses are common and thought to be due to medication noncompliance. Appropriate antifungal therapy and close follow-up are necessary for better outcomes. Re-evaluations must be performed monthly during the first&#x000a0;3 months of treatment and&#x000a0;every&#x000a0;3 months thereafter until the end of the first year. They must include general laboratory, serological, and radiologic tests (the latter to be repeated every 3 to 6 months during the first year).</p>
      </sec>
      <sec id="article-26609.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The most common complication is pulmonary fibrosis. Other common complications include malnourishment, anemia, Addison syndrome, and superinfection with bacteria or other fungal pathogens. Itraconazole has been shown to treat acute infection but does not decrease the risk of pulmonary fibrosis.<xref ref-type="bibr" rid="article-26609.r30">[30]</xref>&#x000a0;Long-term radiologic follow-up of patients with PCM treated with itraconazole did not reveal any improvement in pulmonary fibrosis over a mean follow-up duration of 5.6 years.<xref ref-type="bibr" rid="article-26609.r30">[30]</xref></p>
      </sec>
      <sec id="article-26609.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Prevention of inhalation of the fungus in areas where it is widespread in the environment is impossible. Fortunately, only a small percentage of those infected get sick.&#x000a0;The disease usually affects predominantly males exposed to outdoor environments in rural areas of Central and South America. PCM is considered an occupational disease in some of these areas. Education of the population is fundamental for early diagnosis of the disease and subsequent treatment.&#x000a0;The chronic form of the infection has a strong association with smoking and alcohol intake, so people in endemic areas should be encouraged to avoid these. Tobacco cessation counseling and medications may be of use.</p>
        <p>In immunocompromised patients, most paracoccidioidomycosis infections have been reported in patients with HIV. Lymphomas are the most common hematologic malignancy associated with PCM, and some cases have been reported with kidney transplantation. Clinicians should counsel immunocompromised patients to avoid high-risk exposures before traveling to endemic areas.<xref ref-type="bibr" rid="article-26609.r34">[34]</xref>&#x000a0;A high level of suspicion is needed to provide the best care for these patients.</p>
      </sec>
      <sec id="article-26609.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of&#x000a0;PCM requires&#x000a0;a closely coordinated, interprofessional team approach. The majority of patients present to a primary care provider or emergency clinician. Patients requiring hospitalization may need to be evaluated by pulmonologists and infectious disease specialists. Pharmacists can assist with the dosing of the medications and assist the medical team in avoiding drug-drug interactions. Clinical pharmacists are crucial in monitoring the patient for adverse reactions to therapy, as all antifungals are associated with multiple hepatic and hematologic toxicities. The clinician is essential in educating the patient about the expected long duration of therapy and the risk of complicated disease if treatment is prematurely discontinued. A collaborative interprofessional team can help provide a multifaceted treatment approach for the patient and help improve patient outcomes.</p>
      </sec>
      <sec id="article-26609.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26609&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26609">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/paracoccidioidomycosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26609">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26609/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26609">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26609.s15">
        <title>References</title>
        <ref id="article-26609.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sifuentes-Osornio</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Corzo-Le&#x000f3;n</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Ponce-de-Le&#x000f3;n</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Invasive Fungal Infections in Latin America.</article-title>
            <source>Curr Fungal Infect Rep</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-34</page-range>
            <pub-id pub-id-type="pmid">22363832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Canteros</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>[Paracoccidioidomycosis: chronicle of a neglected disease].</article-title>
            <source>Medicina (B Aires)</source>
            <year>2018</year>
            <volume>78</volume>
            <issue>3</issue>
            <fpage>180</fpage>
            <page-range>180-184</page-range>
            <pub-id pub-id-type="pmid">29940544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teixeira</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Theodoro</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Nino-Vega</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bagagli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Felipe</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Paracoccidioides species complex: ecology, phylogeny, sexual reproduction, and virulence.</article-title>
            <source>PLoS Pathog</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>10</volume>
            <issue>10</issue>
            <fpage>e1004397</fpage>
            <pub-id pub-id-type="pmid">25357210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martinez</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>New Trends in Paracoccidioidomycosis Epidemiology.</article-title>
            <source>J Fungi (Basel)</source>
            <year>2017</year>
            <month>Jan</month>
            <day>03</day>
            <volume>3</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">29371520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brummer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Castaneda</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Restrepo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Paracoccidioidomycosis: an update.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>1993</year>
            <month>Apr</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>89</fpage>
            <page-range>89-117</page-range>
            <pub-id pub-id-type="pmid">8472249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Restrepo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The ecology of Paracoccidioides brasiliensis: a puzzle still unsolved.</article-title>
            <source>Sabouraudia</source>
            <year>1985</year>
            <month>Oct</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>323</fpage>
            <page-range>323-34</page-range>
            <pub-id pub-id-type="pmid">3906945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martinez</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>EPIDEMIOLOGY OF PARACOCCIDIOIDOMYCOSIS.</article-title>
            <source>Rev Inst Med Trop Sao Paulo</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>57 Suppl 19</volume>
            <issue>Suppl 19</issue>
            <fpage>11</fpage>
            <page-range>11-20</page-range>
            <pub-id pub-id-type="pmid">26465364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Restrepo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McEwen</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Casta&#x000f1;eda</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>The habitat of Paracoccidioides brasiliensis: how far from solving the riddle?</article-title>
            <source>Med Mycol</source>
            <year>2001</year>
            <month>Jun</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>233</fpage>
            <page-range>233-41</page-range>
            <pub-id pub-id-type="pmid">11446526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Theodoro</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Teixeira</surname>
                <given-names>Mde M</given-names>
              </name>
              <name>
                <surname>Felipe</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Paduan</surname>
                <given-names>Kdos S</given-names>
              </name>
              <name>
                <surname>Ribolla</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>San-Blas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bagagli</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Genus paracoccidioides: Species recognition and biogeographic aspects.</article-title>
            <source>PLoS One</source>
            <year>2012</year>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>e37694</fpage>
            <pub-id pub-id-type="pmid">22666382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Travassos</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Taborda</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Treatment options for paracoccidioidomycosis and new strategies investigated.</article-title>
            <source>Expert Rev Anti Infect Ther</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>251</fpage>
            <page-range>251-62</page-range>
            <pub-id pub-id-type="pmid">18380607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blotta</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Mamoni</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Nou&#x000e9;r</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Papaiordanou</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Goveia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Camargo</surname>
                <given-names>ZP</given-names>
              </name>
            </person-group>
            <article-title>Endemic regions of paracoccidioidomycosis in Brazil: a clinical and epidemiologic study of 584 cases in the southeast region.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>390</fpage>
            <page-range>390-4</page-range>
            <pub-id pub-id-type="pmid">10497977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quagliato J&#x000fa;nior</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Grangeia</surname>
                <given-names>Tde A</given-names>
              </name>
              <name>
                <surname>Massucio</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>De Capitani</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Rezende</surname>
                <given-names>Sde M</given-names>
              </name>
              <name>
                <surname>Balthazar</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Association between paracoccidioidomycosis and tuberculosis: reality and misdiagnosis.</article-title>
            <source>J Bras Pneumol</source>
            <year>2007</year>
            <season>May-Jun</season>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>295</fpage>
            <page-range>295-300</page-range>
            <pub-id pub-id-type="pmid">17906791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mamoni</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Blotta</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Kinetics of cytokines and chemokines gene expression distinguishes Paracoccidioides brasiliensis infection from disease.</article-title>
            <source>Cytokine</source>
            <year>2005</year>
            <month>Oct</month>
            <day>07</day>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>20</fpage>
            <page-range>20-9</page-range>
            <pub-id pub-id-type="pmid">16174562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marques Mello</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Silva-Vergara</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Patients with active infection with Paracoccidioides brasiliensis present a Th2 immune response characterized by high Interleukin-4 and Interleukin-5 production.</article-title>
            <source>Hum Immunol</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>149</fpage>
            <page-range>149-54</page-range>
            <pub-id pub-id-type="pmid">11821163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Costa</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Benard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Albuquerque</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Fujita</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Magri</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Salge</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Shikanai-Yasuda</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>The lung in paracoccidioidomycosis: new insights into old problems.</article-title>
            <source>Clinics (Sao Paulo)</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>68</volume>
            <issue>4</issue>
            <fpage>441</fpage>
            <page-range>441-8</page-range>
            <pub-id pub-id-type="pmid">23778339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Queiroz-Telles</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Escuissato</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary paracoccidioidomycosis.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>764</fpage>
            <page-range>764-74</page-range>
            <pub-id pub-id-type="pmid">22167404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salzer</surname>
                <given-names>HJF</given-names>
              </name>
              <name>
                <surname>Burchard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cornely</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rolling</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schmiedel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Libman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Capone</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Le</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dalcolmo</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Heyckendorf</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Management of Systemic Endemic Mycoses Causing Pulmonary Disease.</article-title>
            <source>Respiration</source>
            <year>2018</year>
            <volume>96</volume>
            <issue>3</issue>
            <fpage>283</fpage>
            <page-range>283-301</page-range>
            <pub-id pub-id-type="pmid">29953992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buccheri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Khoury</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Barata</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Benard</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Incubation Period and Early Natural History Events of the Acute Form of Paracoccidioidomycosis: Lessons from Patients with a Single Paracoccidioides spp. Exposure.</article-title>
            <source>Mycopathologia</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>181</volume>
            <issue>5-6</issue>
            <fpage>435</fpage>
            <page-range>435-9</page-range>
            <pub-id pub-id-type="pmid">26687074</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Braz&#x000e3;o-Silva</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Andrade</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ribeiro</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>Wdos S</given-names>
              </name>
              <name>
                <surname>Faria</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Faria</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Cardoso</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Loyola</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Paracoccidioidomycosis: a series of 66 patients with oral lesions from an endemic area.</article-title>
            <source>Mycoses</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>e189</fpage>
            <page-range>e189-95</page-range>
            <pub-id pub-id-type="pmid">20406390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellissimo-Rodrigues</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bollela</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Da Fonseca</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Endemic paracoccidioidomycosis: relationship between clinical presentation and patients' demographic features.</article-title>
            <source>Med Mycol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>51</volume>
            <issue>3</issue>
            <fpage>313</fpage>
            <page-range>313-8</page-range>
            <pub-id pub-id-type="pmid">22928923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bocca</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Amaral</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Teixeira</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Shikanai-Yasuda</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Soares Felipe</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Paracoccidioidomycosis: eco-epidemiology, taxonomy and clinical and therapeutic issues.</article-title>
            <source>Future Microbiol</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>8</volume>
            <issue>9</issue>
            <fpage>1177</fpage>
            <page-range>1177-91</page-range>
            <pub-id pub-id-type="pmid">24020744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramos-E-Silva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saraiva</surname>
                <given-names>Ldo E</given-names>
              </name>
            </person-group>
            <article-title>Paracoccidioidomycosis.</article-title>
            <source>Dermatol Clin</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>257</fpage>
            <page-range>257-69, vii</page-range>
            <pub-id pub-id-type="pmid">18346557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shikanai-Yasuda</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Mendes</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Queiroz-Telles</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kono</surname>
                <given-names>ASG</given-names>
              </name>
              <name>
                <surname>Paniago</surname>
                <given-names>AMM</given-names>
              </name>
              <name>
                <surname>Nathan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Valle</surname>
                <given-names>ACFD</given-names>
              </name>
              <name>
                <surname>Bagagli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Benard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Teixeira</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Silva-Vergara</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Cavalcante</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Durlacher</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Khoury</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Camargo</surname>
                <given-names>ZP</given-names>
              </name>
              <name>
                <surname>Moretti</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Brazilian guidelines for the clinical management of paracoccidioidomycosis.</article-title>
            <source>Rev Soc Bras Med Trop</source>
            <year>2017</year>
            <season>Sep-Oct</season>
            <volume>50</volume>
            <issue>5</issue>
            <fpage>715</fpage>
            <page-range>715-740</page-range>
            <pub-id pub-id-type="pmid">28746570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borges</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Chambela</surname>
                <given-names>Mda C</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>Rde V</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Wanke</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Valle</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Itraconazole vs. trimethoprim-sulfamethoxazole: A comparative cohort study of 200 patients with paracoccidioidomycosis.</article-title>
            <source>Med Mycol</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>303</fpage>
            <page-range>303-10</page-range>
            <pub-id pub-id-type="pmid">24577007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Camargo</surname>
                <given-names>ZP</given-names>
              </name>
            </person-group>
            <article-title>Serology of paracoccidioidomycosis.</article-title>
            <source>Mycopathologia</source>
            <year>2008</year>
            <season>Apr-May</season>
            <volume>165</volume>
            <issue>4-5</issue>
            <fpage>289</fpage>
            <page-range>289-302</page-range>
            <pub-id pub-id-type="pmid">18777635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pereira</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Bucaretchi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Barison</surname>
                <given-names>Ede M</given-names>
              </name>
              <name>
                <surname>Hessel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tresoldi</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Paracoccidioidomycosis in children: clinical presentation, follow-up and outcome.</article-title>
            <source>Rev Inst Med Trop Sao Paulo</source>
            <year>2004</year>
            <season>May-Jun</season>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>127</fpage>
            <page-range>127-31</page-range>
            <pub-id pub-id-type="pmid">15286812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Menezes</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Soares</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Fontes</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Drugs for treating paracoccidioidomycosis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2006</year>
            <month>Apr</month>
            <day>19</day>
            <volume>2006</volume>
            <issue>2</issue>
            <fpage>CD004967</fpage>
            <pub-id pub-id-type="pmid">16625617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cavalcante</surname>
                <given-names>Rde S</given-names>
              </name>
              <name>
                <surname>Sylvestre</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Levorato</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>de Carvalho</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Mendes</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Comparison between itraconazole and cotrimoxazole in the treatment of paracoccidiodomycosis.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>e2793</fpage>
            <pub-id pub-id-type="pmid">24743230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naranjo</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Trujillo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Munera</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Restrepo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Restrepo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Treatment of paracoccidioidomycosis with itraconazole.</article-title>
            <source>J Med Vet Mycol</source>
            <year>1990</year>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>67</fpage>
            <page-range>67-76</page-range>
            <pub-id pub-id-type="pmid">2163442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tob&#x000f3;n</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Agudelo</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Osorio</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Arango</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cano</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Restrepo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Residual pulmonary abnormalities in adult patients with chronic paracoccidioidomycosis: prolonged follow-up after itraconazole therapy.</article-title>
            <source>Clin Infect Dis</source>
            <year>2003</year>
            <month>Oct</month>
            <day>01</day>
            <volume>37</volume>
            <issue>7</issue>
            <fpage>898</fpage>
            <page-range>898-904</page-range>
            <pub-id pub-id-type="pmid">13130400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Queiroz-Telles</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Goldani</surname>
                <given-names>LZ</given-names>
              </name>
              <name>
                <surname>Schlamm</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Goodrich</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Espinel-Ingroff</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shikanai-Yasuda</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis.</article-title>
            <source>Clin Infect Dis</source>
            <year>2007</year>
            <month>Dec</month>
            <day>01</day>
            <volume>45</volume>
            <issue>11</issue>
            <fpage>1462</fpage>
            <page-range>1462-9</page-range>
            <pub-id pub-id-type="pmid">17990229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dietze</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Steiner</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Pecanha</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Failure of amphotericin B colloidal dispersion in the treatment of paracoccidioidomycosis.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>1999</year>
            <month>May</month>
            <volume>60</volume>
            <issue>5</issue>
            <fpage>837</fpage>
            <page-range>837-9</page-range>
            <pub-id pub-id-type="pmid">10344661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pe&#x000e7;anha</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>de Souza</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Falqueto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gr&#x000e3;o-Veloso</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>L&#x000ed;rio</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>CU</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>de Souza</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Tuon</surname>
                <given-names>FF</given-names>
              </name>
            </person-group>
            <article-title>Amphotericin B lipid complex in the treatment of severe paracoccidioidomycosis: a case series.</article-title>
            <source>Int J Antimicrob Agents</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>48</volume>
            <issue>4</issue>
            <fpage>428</fpage>
            <page-range>428-30</page-range>
            <pub-id pub-id-type="pmid">27612594</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26609.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Almeida</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Pe&#x000e7;anha-Pietrobom</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Paracoccidioidomycosis in Immunocompromised Patients: A Literature Review.</article-title>
            <source>J Fungi (Basel)</source>
            <year>2018</year>
            <month>Dec</month>
            <day>26</day>
            <volume>5</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30587784</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
